| Code | Description | Claims | Beneficiaries | Total Paid |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
6,708 |
6,023 |
$765K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
36,592 |
21,171 |
$559K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
12,299 |
10,710 |
$252K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
44,408 |
27,989 |
$150K |
| 86328 |
|
1,593 |
1,516 |
$56K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,751 |
1,518 |
$53K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
96 |
96 |
$5K |